Medical/Pharmaceuticals
Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI
* Major finding provides mechanistic explanation for ibezapolstat's (IBZ) selectivity in that the predicted bactericidal interaction between IBZ and its target DNA pol IIIC is conserved across most of the Bacillota phylum, including C. difficile, while certain beneficial taxa are naturally resi...
2025-02-24 21:00
2347
Vantage Foundation Brings Hope and Support to Patients at National Burn Hospital, Hanoi
HANOI, Vietnam, Feb. 24, 2025 /PRNewswire/ -- Vantage Foundation proudly announces its partnership with National Burn Hospital Le Huu Trac inHanoi, a leading medical facility specialising in burn treatments & rehabilitation to provide support and financial assistance to patients of all ages under...
2025-02-24 17:05
3997
AIM Vaccine Integrates DeepSeek: Innovative Technology and Growth Potential Support Valuation Upside
HONG KONG, Feb. 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement onFebruary 23, 2025, announced that the company is fully deploying the DeepSeek large model and promoting the application of DeepSeek R1 version across all business ...
2025-02-24 11:20
3387
NMPA Accepts NDA and Grants Priority Review Designation to Innovent's Ipilimumab Injection, China's First Domestic CTLA-4 Inhibitor, in Combination with Sintilimab as Neoadjuvant Treatment for Colon Cancer
SAN FRANCISCO and SUZHOU, China, Feb. 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...
2025-02-24 07:56
4076
Corti Collaborates with Wolters Kluwer to Bring UpToDate's Trusted Clinical Content to its Specialized AI Platform
Clinicians can now access evidence-based clinical content live during consultations via the Corti Assistant app NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Corti, the leading AI and research company in healthcare, today announced it is collaborating withWolters Kluwer Health to integrate its market-...
2025-02-20 22:00
2700
Syensqo and Emulseo announce strategic partnership for advanced applications in the healthcare sector
Exploring new opportunities within the fast-growing market of microfluidics BORDEAUX, France, Feb. 20, 2025 /PRNewswire/ -- Syensqo, a leading specialty chemicals company, is pleased to announce a strategic partnership with Emulseo, a French company specialized in formulations for microfluidic te...
2025-02-20 21:00
3119
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
MELBOURNE, Australia and INDIANAPOLIS, Ind., Feb. 20, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces its financial results for the year ended31 December 2024. All figures are in AU$ unless stated otherwise. FY2024 highlights * ...
2025-02-20 20:23
4459
Check PD: New Parkinson's Screening App with 90% Accuracy--Download Now!
BANGKOK, Feb. 20, 2025 /PRNewswire/ -- King Chulalongkorn Memorial Hospital
2025-02-20 10:00
3111
BluMaiden Biosciences Appoints New US-based Leadership to Accelerate Global Expansion
- Dr. Terence Kelly named interim CEO and Prof. Damian O'Connell named Chair of the Scientific Advisory Board, joins Board of Directors - Appointment of US-based CEO completes the recent build out of BluMaiden's executive team in preparation for commercialization, supported by COO Dr....
2025-02-19 20:00
3077
Ascletis Announces Positive Interim Results from First Two Cohorts of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30
- ASC30 oral once-daily tablet demonstrated a 6.3% mean body weight reduction from baseline after 28-day treatment in multiple ascending dose (MAD)cohort 2 (weekly titrations of 2 mg, 10 mg, 20 mg, and 40 mg). - ASC30 oral once-daily tablet also demonstrated a 4.3% mean body weight reduction fr...
2025-02-19 20:00
4261
Hong Kong to Host Landmark International Symposium on Genomic Medicine
HKGI Partners with Global Leaders to Chart a Course for Healthcare Transformation HONG KONG, Feb. 19, 2025 /PRNewswire/ -- Genomic medicine has been gaining global prominence for its vast potential to revolutionise healthcare services. In the case of rare conditions, genomic medicine has been pa...
2025-02-19 11:43
3809
SingHealth and Philips sign MOU to advance digital-first healthcare to future-proof care delivery
* New partnership set to accelerate digital healthcare transformation in Singapore, with a focus on co-designing and integrating Artificial Intelligence (AI) and predictive data management to improve patient care by 2028 * Projects under this partnership aim to: o Streamline imaging data wor...
2025-02-19 10:13
3674
Berlin Heals Holding AG Successfully Raises Over 7Million CHF Round for Initiating First Studies of New Less Invasive Approaches
ZUG, Switzerland, Feb. 18, 2025 /PRNewswire/ -- Berlin Heals Holding AG, a late stage MedTech start up, has developed a breakthrough method and a product for the therapy of heart failure. The product - an electronic device called C-MIC - has already successfully been tested in patients in a pilot...
2025-02-18 23:20
3247
CMI Media Group unveils inaugural Media Vitals HCP Global research
LONDON, Feb. 18, 2025 /PRNewswire/ -- Healthcare agency CMI Media Group, a WPP company (NYSE: WPP), has unveiled its first ever Media Vitals(TM) HCP Global research. The new report provides insights into the media preferences of healthcare professionals (HCPs) on a global scale. Insights were ga...
2025-02-18 21:25
2870
TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant
TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311, the world's first Apixaban oral dissolving film (ODF). The study confirmed that TAH3311 is bioequivalent to U.S. and European reference Apixaban tablets (Eliquis®) ...
2025-02-17 21:03
3867
3Z Pharmaceuticals Unveils Landmark Study Supporting Calcium Channel Blocker as a Groundbreaking ADHD Therapy
REYKJAVIK, Iceland, Feb. 17, 2025 /PRNewswire/ -- 3Z Pharmaceuticals today announced the publication of a transformative study in Neuropsychopharmacology, highlighting compelling scientific evidence that positions the mechanisms engaged by amlodipine, an L-type calcium channel blocker (LTCC), as...
2025-02-17 19:25
2552
Singapore launches Mental Health Innovation Asia Hub at international symposium
* High demand: Mental health now tops health concerns in Singapore, surpassing cancer and COVID-19. * New regional hub: MHIN Asia Hub, based in Singapore, aims to share innovative resources and ideas to promote mental health support across Asia. SINGAPORE, Feb. 17, 2025 /PRNewswire/ -- In a s...
2025-02-17 18:20
4759
Baltics leading pharmaceutical company Grindeks expands to new export markets worldwide
RIGA, Latvia, Feb. 17, 2025 /PRNewswire/ -- The leading pharmaceutical company in the Baltics, Grindeks, continues to strengthen its global presence by entering new export markets. This year, for the first time, Grindeks products will be delivered toPanama. The company's export markets already in...
2025-02-17 15:00
3828
Stryker launches ProCeed hospital bed
New hospital bed helps caregivers deliver efficient and quality care in markets outside the U.S. PORTAGE, Mich., Feb. 17, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of the ProCeed hospital bed, offering simplicity while enhancing care a...
2025-02-17 08:07
2921
Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, Feb. 17, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metaboli...
2025-02-17 08:00
4193
Week's Top Stories
Most Reposted
SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 282 media titles]
2026-10-07 11:50DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 279 media titles]
2026-10-06 05:28Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 274 media titles]
2026-10-09 13:21Southeast Asia's China travel map is widening, Traveloka platform data shows
[Picked up by 263 media titles]
2026-10-05 11:51Most Read
Nuix Neo Generative AI Framework
2026-10-08 08:02
9127
Silicon Quantum Computing Named to Fast Company's 2026 Next Big Things in Tech List
2026-10-06 19:38
8163
DayOne Files Registration Statement for Proposed Initial Public Offering
2026-10-06 05:28
7981